Physical rehabilitation of children with perinatal lesion of the central nervous system

2021 ◽  
pp. 29-39
Author(s):  
M.A. Khan ◽  
Prikuls V.F. Prikuls V.F. ◽  
N.A. Mikitchenko ◽  
O.Yu. Smotrina ◽  
Filatova E.V. Filatova E.V.
Keyword(s):  
Central Nervous System ◽  
Nervous System ◽  
Muscle Tone ◽  
Medical Rehabilitation ◽  
Psychomotor Development ◽  
Rehabilitation Team ◽  
Perinatal Pathology ◽  
Wide Range ◽  
The Central Nervous System ◽  
Rehabilitation Measures

The article is dedicated to non-pharmacological rehabilitation of children with perinatal lesions of the central nervous system. Currently, the main methodological principles of the staged medical rehabilitation of newborns, mainly children with consequences of perinatal damage to the nervous system, have been determined. Special attention should be paid to the issue of the minimum use of drugs in children with perinatal pathology. In this regard, an important task is to develop and scientifically substantiate new non-drug technologies for medical rehabilitation, especially in children under 1 year of age. Medical rehabilitation has the following aims: stimulation of blood circulation in the tissues of the brain, improvement of muscle tone by acting on the central nervous system and the peripheral nervous system, activation of the processes of neuromuscular transmission and improvement of the psychomotor development of a child with perinatal pathology of the central nervous system. Medical rehabilitation of children with perinatal lesions of the central nervous system begins at the earliest possible date and is carried out by specialists of a multidisciplinary rehabilitation team based on an individual medical rehabilitation program. At present, a wide range of non-drug technologies for medical rehabilitation of children with the consequences of perinatal damage to the central nervous system is used: therapeutic gymnastics, massage, kinesitherapy with a neuroreflex component according to the V. Vojta’s method, Bobath therapy. The analysis of publications presented in the review has shown that the inclusion of modern technologies of kinesitherapy and massage in the complex of rehabilitation measures in children with perinatal lesions can increase the effectiveness of rehabilitation measures, reduce the severity of movement disorders, and decrease the incidence of cerebral palsy.

scholarly journals Modern Physical Rehabilitation Technologies for Children with Perinatal Lesions of the Central Nervous System

2021 ◽  
Vol 20 (4) ◽  
pp. 57-64
Author(s):  
Maya A. Khan ◽  
Maria S. Petrova ◽  
Maria G. Degtyareva ◽  
Natalya A. Mikitchenko ◽  
Olga U. Smotrina ◽  
...  
Keyword(s):  
Central Nervous System ◽  
Nervous System ◽  
Physical Rehabilitation ◽  
Medical Rehabilitation ◽  
Psychomotor Development ◽  
Cochrane Library ◽  
Rehabilitation Team ◽  
Perinatal Pathology ◽  
Wide Range ◽  
The Central Nervous System

The subject of this publication is the medical rehabilitation of children with perinatal lesions of the central nervous system. Currently, the main methodological principles of stage-by-stage medical rehabilitation of newborns, mainly children with the consequencesof perinatal damage to the nervous system, have been determined. Special attention should be paid to the issue of minimal use of medicines in children with perinatal pathology, in this regard, an importanttask is the development and scientific justification of new non-drug technologies of medical rehabilitation, especially in childrenunder 1 year. Medical rehabilitation sets itself the following tasks: stimulation of blood circulation in the brain tissues, improvement of muscle toneby affecting the central nervous system and the peripheral nervous system, activation of neuromuscular transmission processes andimprovement of psychomotor development of a child with perinatal pathology of the central nervous system. Medical rehabilitationof children with perinatal lesions of the central nervous system begins at the earliest possible time and is carried out by specialists ofa multidisciplinary rehabilitation team based on an individual medical rehabilitation program. Aim. To study the results of research conducted by Russian and foreign authors on the issues of physical rehabilitation of children withperinatal damage to the central nervous system and to conduct an analysis of the effectiveness of the proposed technologies. Material and methods. The literature review for this article was conducted from the elibrary, PubMed, Cochrane Library databaseswith a search depth of 10 years. The selection of publications was carried out using keywords: non-drug technologies, perinatal damageto the central nervous system; perinatal hypoxic-ischemic encephalopathy, kinesotherapy, neurodevelopmental therapy, massage,thin finger training method, dry immersion, fitball gymnastics, V. Voit therapy; Bobat therapy. Conclusion. Currently, a wide range of non-drug technologies of medical rehabilitation of children with the consequences of perinataldamage to the central nervous system is used such as therapeutic gymnastics, massage, kinesiotherapy with a neuroreflex locomotionaccording to Vojta’s method, Bobath-therapy, massage, etc. The analysis of publications has shown that kinesotherapy and massagein in the complex of rehabilitation measures for children with perinatal lesions allows to increase the effectiveness of rehabilitationmeasures, reduce the severity of motor disorders, and can help reduce the frequency of formation of cerebral palsy.

Methods of Physiotherapy in the Medical Rehabilitation of Children with Primary Arterial Hypertension

2020 ◽  
Vol 98 (4) ◽  
pp. 55-61
Author(s):  
L.V. Kuyantseva ◽  
E.A. Turova ◽  
I.I. Trunina ◽  
M.S. Petrova ◽  
I.A. Lomaga
Keyword(s):  
Blood Pressure ◽  
Central Nervous System ◽  
Nervous System ◽  
Arterial Hypertension ◽  
Self Regulation ◽  
Medical Rehabilitation ◽  
Medication Therapy ◽  
Wide Range ◽  
Treatment Of Hypertension ◽  
The Central Nervous System

Introduction. Arterial hypertension (AH) is a widely occurring disease of the cardiovascular system in the children’s population, which often debuts in childhood, persists into adulthood, which dictates the need for early treatment and prevention of arterial hypertension. The formation of AH is associated with maladaptation of physiological mechanisms of self-regulation, with a complex interaction of psychosocial and genetic factors. The use of non-medicinal agents to reduce blood pressure is a starting approach in the treatment of children and adolescents with hypertension and complements medication therapy. Purpose. analysis of literature sources on the effectiveness of hardware physiotherapy methods in the treatment of hypertension in children. Discussion. In the treatment of children with hypertension, the leading role belongs to hardware physiotherapy technologies. Widely used sedative, hypotensive and vegetative-corrective methods are pathogenetically justified and can be used at all stages of arterial hypertension development. Transcranial pulsed electrotherapy (transcranial electrostimulation, electroson, infitotherapy), darsonvalization, aromafitotherapy and medicinal electrophoresis of sedatives belong sedative methods aimed at enhancing inhibitory processes in the Central nervous system. Amplipulster therapy, intermittent normobaric hypoxytherapy, low-intensity magnetic therapy, medicinal electrophoresis of spasmolytic drugs, EHF therapy, laser therapy, which lead to a decrease in arterial hypertension and improve microcirculation, are hypotensive methods. Bio-controlled aerionotherapy, aimed at correcting vegetative dysfunction, is a vegetative corrective method. Conclusion. Currently, there is a wide range of scientifically-based methods of hardware physiotherapy used in the medical rehabilitation of children with arterial hypertension, allowing to improve cerebral hemodynamics, normalize neurophysiological and hemodynamic processes in the Central nervous system, provide sedative and hypotensive effects, stimulate peripheral vasodepressor mechanisms, normalize neuroendocrine processes. The use of hardware physiotherapy methods in the complex treatment of hypertension can improve the quality of life of patients, achieve stable normalization of blood pressure, and reduce the risk of early cardiovascular diseases.

scholarly journals Distribution of the prion protein in sheep terminally affected with BSE following experimental oral transmission

2001 ◽  
Vol 82 (10) ◽  
pp. 2319-2326 ◽  
Author(s):  
J. D. Foster ◽  
D. W. Parnham ◽  
N. Hunter ◽  
M. Bruce
Keyword(s):  
Central Nervous System ◽  
Nervous System ◽  
Experimental Infection ◽  
Oral Route ◽  
Similar Distribution ◽  
Peripheral Tissues ◽  
Oral Transmission ◽  
Wide Range ◽  
Direct Contrast ◽  
The Central Nervous System

This study has examined the distribution of PrPSc in sheep by immunocytochemistry of tissues recovered from terminally affected animals following their experimental infection by the oral route with BSE. Despite a wide range of incubation period lengths, affected sheep showed a similar distribution of high levels of PrPSc throughout the central nervous system. PrPSc was also found in the lymphoid system, including parts of the digestive tract, and some components of the peripheral nervous system. These abundant PrPSc deposits in sheep in regions outside the central nervous system are in direct contrast with cattle infected with BSE, which show barely detectable levels of PrPSc in peripheral tissues. A number of genetically susceptible, challenged animals appear to have survived.

scholarly journals Magnetic Iron Oxide Nanoparticles: Synthesis, Characterization and Functionalization for Biomedical Applications in the Central Nervous System

Materials ◽  
2019 ◽  
Vol 12 (3) ◽  
pp. 465 ◽  
Author(s):  
Shoeb Ansari ◽  
Eleonora Ficiarà ◽  
Federico Ruffinatti ◽  
Ilaria Stura ◽  
Monica Argenziano ◽  
...  
Keyword(s):  
Central Nervous System ◽  
Nervous System ◽  
Iron Oxide ◽  
Iron Oxide Nanoparticles ◽  
Oxide Nanoparticles ◽  
Magnetic Iron Oxide Nanoparticles ◽  
Close Link ◽  
Wide Range ◽  
Methods Of Synthesis ◽  
The Central Nervous System

Magnetic Nanoparticles (MNPs) are of great interest in biomedicine, due to their wide range of applications. During recent years, one of the most challenging goals is the development of new strategies to finely tune the unique properties of MNPs, in order to improve their effectiveness in the biomedical field. This review provides an up-to-date overview of the methods of synthesis and functionalization of MNPs focusing on Iron Oxide Nanoparticles (IONPs). Firstly, synthesis strategies for fabricating IONPs of different composition, sizes, shapes, and structures are outlined. We describe the close link between physicochemical properties and magnetic characterization, essential to developing innovative and powerful magnetic-driven nanocarriers. In conclusion, we provide a complete background of IONPs functionalization, safety, and applications for the treatment of Central Nervous System disorders.

scholarly journals Drugs modulating the L-arginine:NO:cGMP pathway – current use in therapy

2016 ◽  
Vol 29 (1) ◽  
pp. 14-20 ◽  
Author(s):  
Magdalena Polakowska ◽  
Jolanta Orzelska-Gorka ◽  
Sylwia Talarek
Keyword(s):  
Nitric Oxide ◽  
Central Nervous System ◽  
Nervous System ◽  
Cardiovascular Diseases ◽  
Significant Role ◽  
Current Understanding ◽  
Physiological Processes ◽  
Wide Range ◽  
The Central Nervous System ◽  
Pharmacological Profiles

AbstractNitric oxide (NO) is a relatively novel messenger that plays a significant role in a wide range of physiological processes. Currently, it is known that, both, lack and excess of NO can cause diseases, thus a lot of substances have been discovered and utilized which can change the concentration of this molecule within the organism. The aim of the present work is to provide an overview of currently used agents modulating the L-arginine:NO:cGMP pathway, as well as to summarize current understanding of their pharmacological profiles. Nowadays, most of these agents are employed particularly in the treatment of cardiovascular diseases. Further studies can hold promise for enhancing the therapeutic equipment for a variety of other impairments, such as osteoporosis, and also in treatments of the central nervous system.

scholarly journals Synthesis and pharmacological properties of 3-(2-methyl-furan-3-yl)-4-substituted-Δ2-1,2,4-triazoline-5-thiones

2008 ◽  
Vol 6 (1) ◽  
pp. 47-53 ◽  
Author(s):  
Agata Siwek ◽  
Monika Wujec ◽  
Maria Dobosz ◽  
Ewa Jagiełło-Wójtowicz ◽  
Anna Chodkowska ◽  
...  
Keyword(s):  
Central Nervous System ◽  
Nervous System ◽  
Carboxylic Acid ◽  
Acid Hydrazide ◽  
Pharmacological Properties ◽  
Pharmacological Effects ◽  
Carboxylic Acid Hydrazide ◽  
Wide Range ◽  
The Central Nervous System

AbstractBy the reaction of 2-methyl-furan-3-carboxylic acid hydrazide with isothiocyanates, 1-[(2-methyl-furan-3-yl)carbonyl]-4-substituted thiosemicarbazides 1 were obtained. Further cyclization with 2% NaOH led to the formation of 3-(2-methyl-furan-3-yl)-4-substituted-Δ2-1,2,4-triazoline-5-thiones 2. The pharmacological effects of 2 on the central nervous system in mice were investigated. Strong antinociceptive properties of the investigated derivatives were observed in a wide range of doses.

scholarly journals Mechanism of penile erection

2017 ◽  
Author(s):  
Selim Cellek
Keyword(s):  
Central Nervous System ◽  
Nervous System ◽  
Smooth Muscle ◽  
Erectile Function ◽  
Penile Erection ◽  
Muscle Tone ◽  
Main Determinant ◽  
Smooth Muscle Tone ◽  
Sexual Stimuli ◽  
The Central Nervous System

Sexual stimuli (tactile, visual, olfactory, and imaginative) are processed and integrated in the central nervous system which then activates certain autonomic and somatic pathways within the peripheral nervous system. This coordinated activation of the central and peripheral nervous systems leads to penile erection which is actually a result of relaxation of vascular and cavernosal smooth muscle in the penis. In the flaccid (detumescent) penis, the smooth muscle tone is heightened. Penile erection (tumescence) requires a decrease in the smooth muscle tone. The tone of the penile smooth muscle therefore is the main determinant of erectile function. In this chapter, the current information on the control of erectile function by this central-peripheral-smooth muscle axis will be reviewed.

scholarly journals The Effect of Melatonin Modulation of Non-coding RNAs on Central Nervous System Disorders: An Updated Review

2020 ◽  
Vol 19 (1) ◽  
pp. 3-23
Author(s):  
Jianan Lu ◽  
Yujie Luo ◽  
Shuhao Mei ◽  
Yuanjian Fang ◽  
Jianmin Zhang ◽  
...  
Keyword(s):  
Central Nervous System ◽  
Nervous System ◽  
Circular Rna ◽  
Future Research ◽  
Protective Function ◽  
Messenger Ribonucleic Acid ◽  
Wide Range ◽  
The Central Nervous System ◽  
Non Coding Rnas ◽  
Regulatory Effects

: Melatonin is a hormone produced in and secreted by the pineal gland. Besides its role in regulating circadian rhythms, melatonin has a wide range of protective functions in the central nervous system (CNS) disorders. The mechanisms underlying this protective function are associated with the regulatory effects of melatonin on related genes and proteins. In addition to messenger ribonucleic acid (RNA) that can be translated into protein, an increasing number of non-coding RNAs in the human body are proven to participate in many diseases. This review discusses the current progress of research on the effects of melatonin modulation of non-coding RNAs (ncRNAs), including microRNA, long ncRNA, and circular RNA. The role of melatonin in regulating common pathological mechanisms through these ncRNAs is also summarized. Furthermore, the ncRNAs, currently shown to be involved in melatonin signaling in CNS diseases, are discussed. The information compiled in this review will open new avenues for future research into melatonin mechanisms and provide a further understanding of ncRNAs in the CNS.

scholarly journals Modern aspects of neuropathogenesis and neurological manifestations of COVID-19

2021 ◽  
Vol 17 (2) ◽  
pp. 6-15
Author(s):  
L.A. Dziak ◽  
O.S. Tsurkalenko ◽  
K.V. Chekha ◽  
V.M. Suk
Keyword(s):  
Central Nervous System ◽  
Nervous System ◽  
Psychiatric Symptoms ◽  
Clinical Manifestations ◽  
The Body ◽  
Altered Level ◽  
Wide Range ◽  
The Central Nervous System ◽  
The Brain

Coronavirus infection is a systemic pathology resulting in impairment of the nervous system. The involvement of the central nervous system in COVID-19 is diverse by clinical manifestations and main mechanisms. The mechanisms of interrelations between SARS-CoV-2 and the nervous system include a direct virus-induced lesion of the central nervous system, inflammatory-mediated impairment, thrombus burden, and impairment caused by hypoxia and homeostasis. Due to the multi-factor mechanisms (viral, immune, hypoxic, hypercoagulation), the SARS-CoV-2 infection can cause a wide range of neurological disorders involving both the central and peripheral nervous system and end organs. Dizziness, headache, altered level of consciousness, acute cerebrovascular diseases, hypogeusia, hyposmia, peripheral neuropathies, sleep disorders, delirium, neuralgia, myalgia are the most common signs. The structural and functional changes in various organs and systems and many neurological symptoms are determined to persist after COVID-19. Regardless of the numerous clinical reports about the neurological and psychiatric symptoms of COVID-19 as before it is difficult to determine if they are associated with the direct or indirect impact of viral infection or they are secondary to hypoxia, sepsis, cytokine reaction, and multiple organ failure. Penetrated the brain, COVID-19 can impact the other organs and systems and the body in general. Given the mechanisms of impairment, the survivors after COVID-19 with the infection penetrated the brain are more susceptible to more serious diseases such as Parkinson’s disease, cognitive decline, multiple sclerosis, and other autoimmune diseases. Given the multi-factor pathogenesis of COVID-19 resulting in long-term persistence of the clinical symptoms due to impaired neuroplasticity and neurogenesis followed by cholinergic deficiency, the usage of Neuroxon® 1000 mg a day with twice-day dosing for 30 days. Also, a long-term follow-up and control over the COVID-19 patients are recommended for the prophylaxis, timely determination, and correction of long-term complications.

Sign in / Sign up

Export Citation Format

Share Document